leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 23:11:10 - browse：35622

This image provided by Amylyx Pharmaceuticals shows the drug Relyvrio. The maker of a much-debated drug for Lou Gehrig’s disease said Friday, March 8, 2024 its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market. — Relyvrio, an ALS drug made by Amylyx Pharmaceuticals, failed to beat placebo in a key clinical trial. Amylyx Pharmaceuticals via AP

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work.

Amylyx Pharmaceuticals’ announcement Friday that its drug, marketed as Relyvrio, failed to beat placebo in a pivotal study marks “a sad day for us, but we have to believe the data,” said Mary Catherine Collet, an ALS advocate. “These are hard scientific facts that we have to face, and I appreciate that they’re not trying to spin us like some cheerleading practice.”

The question now is whether Relyvrio, approved in 2022, should be removed from the market entirely — and whether the Food and Drug Administration made a mistake by authorizing it in the first place. After years of pressure from patient advocates, the agency has taken a more flexible approach to medicines for devastating, incurable diseases like ALS. But the case of Relyvrio, which made $381 million in sales and $49 million in profit for Amylyx last year, has underlined questions about the limits of regulatory leniency.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Obesity experts on risks of Wegovy, Ozempic weight loss drugs

hotspot

WSS

Mitch McConnell episode has important public health takeaway

With FDA staff opposed to Sarepta therapy, top official intervened

5 important ways Henrietta Lacks changed medical science

WATCH: Why do fingernails fall off when they're damaged?

The science behind Janet Jackson's pregnancy at 49

With FDA staff opposed to Sarepta therapy, top official intervened

explore

leisure time

explore

Medical records are filled with copy

Pence says 'crackpot lawyers' told Trump what he wanted to hear

At least 13 dead in Texas as scorching temps continue

What to expect as Trump is arraigned on his Jan 6. indictment

In age of alternative facts, a scholarly course on calling out crap

Micronoma's microbiome cancer diagnostic approach under fire

How one medical school became remarkably diverse

Why we need to separate burnout from moral injury in health care

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Wikipedia

The science behind Janet Jackson's pregnancy at 49

Sage hopes for a blockbuster in antidepressant now before FDA

Why we need to separate burnout from moral injury in health care

Do masks work? RCTs can't tell us

Physician groups backed by private equity giant lobby on mergers

Lawsuit alleges UnitedHealth Group unit illegally denied claims

focus

hotspot

leisure time

knowledge